NDA 205739 describes VELTASSA, which is a drug marketed by Relypsa Inc and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug. Additional details are available on the VELTASSA profile page.
The generic ingredient in VELTASSA is patiromer sorbitex calcium. One supplier is listed for this compound. Additional details are available on the patiromer sorbitex calcium profile page.
Patent: ➤ Try a Free Trial Patent Expiration: Feb 27, 2025 Product Flag? Substance Flag? Delist Request?
Patent: ➤ Try a Free Trial Patent Expiration: Mar 11, 2026 Product Flag? Y Substance Flag? Delist Request?